SMA-MAP - Myriad RBM

Human SMA-MAP v. 1.0

SMA-MAP is a quantitative service measuring 27 plasma proteins associated with motor function and other outcome measures for Spinal Muscular Atrophy (SMA). SMA is a devastating neuromuscular disease that is the leading genetic cause of death in infants and toddlers, and causes progressive and debilitating weakness in older children and adults. These 27 markers have been evaluated in multiple SMA patient collections and several of these proteins are expressed in tissues that include the central nervous system and/or muscle. SMA-MAP provides a comprehensive and efficient platform for biomarker validation and may help accelerate the development of new treatments for SMA.

KidneyMAP MicrositeMore about SMA-MAP »
Publications | Webinars | Posters

Sample Volume Requirements
Click or mouse over biomarkers for more information.
Analytes included in this MAP are subject to change.
1. AXL Receptor Tyrosine Kinase 2. Apolipoprotein B
3. C-Reactive Protein 4. Cadherin-13
5. Cartilage Oligomeric Matrix Protein 6. Cathepsin D
7. Complement Factor H – Related Protein 1 8. Complement component C1q receptor
9. Dipeptidyl peptidase IV 10. Endoglin
11. Fetuin-A 12. Fibulin-1C
13. Human Epidermal Growth Factor Receptor 2 14. Insulin-like Growth Factor Binding Protein 6
15. Leptin 16. Monocyte Chemotactic Protein 1
17. Myoglobin 18. Osteopontin
19. Peptidase D 20. Placenta Growth Factor
21. Serum Amyloid P-Component 22. Tenascin-X
23. Tetranectin 24. Thrombospondin-4
25. YKL-40

Intended for Research Use Only.